Mutations of p53 in Thyroid Carcinoma with an Insular Component
- 1 April 1999
- journal article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 9 (4) , 377-381
- https://doi.org/10.1089/thy.1999.9.377
Abstract
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amplified by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.Keywords
This publication has 16 references indexed in Scilit:
- Insular component as a risk factor of thyroid carcinomaPathology International, 1996
- p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomasHuman Pathology, 1996
- A Universal Method for the Mutational Analysis of K-ras and p53 Gene in Non-small-cell Lung Cancer Using Formalin-Fixed Paraffin-Embedded TissueDiagnostic Molecular Pathology, 1995
- Stepwise Participation of p53 Gene Mutation During Dedifferentiation of Human Thyroid CarcinomasDiagnostic Molecular Pathology, 1994
- Analysis of p53 Gene Mutations in Human Gliomas by Polymerase Chain Reaction-Based Single-Strand Conformation Polymorphism and DNA SequencingDiagnostic Molecular Pathology, 1994
- Genetic Alterations in Thyroid Tumor Progression: Association with p53 Gene MutationsJapanese Journal of Cancer Research, 1993
- Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.Journal of Clinical Investigation, 1993
- High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.Journal of Clinical Investigation, 1993
- Characterization of the human p53 gene.Molecular and Cellular Biology, 1986
- Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomasCancer, 1983